Organovo Holdings, Inc.
(NYSE Amex Equities : ONVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading ONVO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.01%83.101.8%$753.16m
BIIBBiogen Inc.
0.92%241.111.0%$580.18m
CELGCelgene Corporation
-0.36%98.451.2%$471.89m
AMGNAmgen Inc.
1.15%151.831.0%$447.19m
REGNRegeneron Pharmaceuticals, Inc.
0.17%348.443.1%$328.41m
ALXNAlexion Pharmaceuticals, Inc.
1.87%116.312.5%$302.71m
ILMNIllumina, Inc.
1.48%139.614.9%$167.73m
VRTXVertex Pharmaceuticals Incorporated
0.84%85.712.6%$134.68m
MDVNMedivation, Inc.
-1.13%60.262.8%$130.83m
BMRNBioMarin Pharmaceutical Inc.
-0.41%78.054.0%$127.71m
TSROTESARO, Inc.
6.47%82.4115.8%$120.56m
SRPTSarepta Therapeutics, Inc.
1.72%18.9849.4%$107.73m
AAgilent Technologies, Inc.
1.14%44.261.0%$104.05m
CPXXCelator Pharmaceuticals, Inc.
0.03%30.228.5%$102.12m
EXASExact Sciences Corporation
8.99%12.3121.4%$98.07m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.